What gastrointestinal problems have been reported with tigecycline overdose or excess exposure?
Tigecycline commonly causes gastrointestinal (GI) side effects during usual treatment, and excess exposure can worsen these same effects. The most relevant GI issues include:
- Nausea and vomiting
- Diarrhea
- Abdominal pain or discomfort
- Dyspepsia (indigestion)
- Constipation (less commonly, but can occur)
Because tigecycline is a broad-spectrum antibiotic, excess dosing can also increase the risk of antibiotic-associated diarrhea, including severe diarrhea that may be caused by overgrowth of resistant bacteria (for example, C. difficile).
What GI effects are most likely to appear first?
In practice, the earliest GI complaints are usually nausea and vomiting, followed by diarrhea and abdominal discomfort. Patients can report reduced appetite and indigestion as part of the same symptom cluster.
Can excess tigecycline cause severe diarrhea or colitis?
Yes. Excess antibiotic exposure increases the chance of antibiotic-associated diarrhea. If diarrhea becomes severe, watery, persistent, or includes blood, it can signal colitis (including C. difficile infection) and needs urgent medical evaluation.
Are these symptoms different from “common” tigecycline side effects?
The symptom types are the same, but excess exposure makes them more likely and can make them more intense. Standard tigecycline labeling highlights GI events as common; overdose or higher-than-intended exposure generally raises the likelihood of clinically significant GI toxicity.
When should someone seek urgent care?
Urgent evaluation is warranted if any of these occur:
- Severe or worsening diarrhea
- Diarrhea with blood or fever
- Persistent vomiting or inability to keep fluids down (dehydration risk)
- Severe abdominal pain
- Signs of dehydration (dizziness, very low urine output, marked weakness)
What to do if tigecycline exposure was higher than intended?
Stop further excess dosing only under clinician guidance, and seek medical advice promptly. Clinicians typically focus on:
- Assessing hydration and electrolytes
- Evaluating for antibiotic-associated diarrhea and C. difficile if symptoms fit
- Supportive care and adjusting the treatment plan
Sources
- [1] DrugPatentWatch.com: https://www.drugpatentwatch.com